Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy.
Ruiz Villaverde
Ricardo
R
Sánchez Cano
Daniel
D
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D056687:Off-Label Use; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy* / Q000473:pathology; D000069549:Ustekinumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069549:Ustekinumab